A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)

Conditions:   Colorectal Cancer;   Triple Negative Breast Cancer;   Pancreatic Cancer;   Non-Small Cell Lung Cancer;   Head and Neck Cancer;   Ovarian Cancer;   Lymphoma;   Sarcoma;   Bladder Cancer;   Melanoma;   IDH1 Mutated Solid Tumors;   IDH1 Mutated or MGMT Methylated Recurrent High Grade Glioma
Interventions:   Biological: Toca 511;   Drug: Toca FC
Sponsor:   Tocagen Inc.
Recruiting - verified September 2017

http://ift.tt/2xhH5Kn